Downregulation of Glutathione S‑transferase A1 suppressed tumor growth and induced cell apoptosis in A549 cell line

Liu,Huan; Yang,Zhouping; Zang,Linquan; Wang,Guixiang; Zhou,Sigui; Jin,Guifang; Yang,Zhicheng; Pan,Xuediao

doi:10.3892/ol.2018.8608

Downregulation of Glutathione S‑transferase A1 suppressed tumor growth and induced cell apoptosis in A549 cell line

Authors:
- Huan Liu
- Zhouping Yang
- Linquan Zang
- Guixiang Wang
- Sigui Zhou
- Guifang Jin
- Zhicheng Yang
- Xuediao Pan
View Affiliations

Affiliations: College of Pharmacy, Guangdong Pharmaceutical University, Guangzhou, Guangdong 510006, P.R. China, Department of Pharmacy, Guangdong 999 Brain Hospital, Guangzhou, Guangdong 510510, P.R. China
Published online on: May 2, 2018 https://doi.org/10.3892/ol.2018.8608
Pages: 467-474

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Glutathione S‑transferase A1 (GSTA1) is a phase II detoxification enzyme and serves a crucial role in anti‑cancer drug resistance. In our previous study, GSTA1 was identified to be highly expressed in various subtypes of non‑small‑cell lung cancer cell lines compared with human embryonic lung fibroblast cell line MRC‑5. The aim of the present study was to investigate the effect of GSTA1 expression on the proliferation and apoptosis of A549 cells. GSTA1 expression was knocked down or with overexpressed using lentivirus particles. Western blot analysis and reverse transcription‑quantitative polymerase chain reaction (RT‑qPCR) were used to assess the protein, and mRNA levels of GSTA1 in A549 cells, respectively. The effect of GSTA1 manipulation on cell proliferation and apoptosis were investigated in vitro using MTT assays, Hoechst 33258 staining and flow cytometry, and in vivo using A549 cell line xenografts in nude mice. The results of the western blot analysis and RT‑qPCR revealed that stable cell models of GSTA1 knockdown, and overexpression were established. The data of the MTT assay indicated that the downregulation of GSTA1 significantly inhibited cell proliferation compared with si‑control‑transfected cells. These si‑GSTA1 A549 cells exhibited typical morphological changes of apoptosis, including chromatin condensation and shrunken nuclei compared with the si‑control counterparts. An AnnexinV‑fluorescein isothiocyanate assay verified that the downregulation of GSTA1 significantly induced cell apoptosis in vitro. In addition, overexpression of GSTA1 significantly promoted tumor growth in vivo. Accordingly, downregulation of GSTA1 suppressed tumor growth. In conclusion, GSTA1 plays an important role in regulation of cell proliferation and cell apoptosis in A549 cell line.

View Figures

View References

1	Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015. View Article : Google Scholar : PubMed/NCBI
2	Siegel RL, Miller KD and Jemal A: Cancer statistics, 2016. CA Cancer J Clin. 66:7–30. 2016. View Article : Google Scholar : PubMed/NCBI
3	Sher T, Dy GK and Adjei AA: Small cell lung cancer. Mayo Clin Proc. 83:355–367. 2008. View Article : Google Scholar : PubMed/NCBI
4	Zappa C and Mousa SA: Non-small cell lung cancer: Current treatment and future advances. Transl Lung Cancer Res. 5:288–300. 2016. View Article : Google Scholar : PubMed/NCBI
5	Zang L, Shi L, Guo J, Pan Q, Wu W, Pan X and Wang J: Screening and identification of a peptide specifically targeted to NCI-H1299 from a phage display peptide library. Cancer Lett. 281:64–70. 2009. View Article : Google Scholar : PubMed/NCBI
6	Singh S: Cytoprotective and regulatory functions of glutathione S-transferases in cancer cell proliferation and cell death. Cancer Chemother Pharmacol. 75:1–15. 2015. View Article : Google Scholar : PubMed/NCBI
7	Board PG and Menon D: Glutathione transferases, regulators of cellular metabolism and physiology. Biochim Biophys Acta. 1830:3267–3288. 2013. View Article : Google Scholar : PubMed/NCBI
8	Townsend DM and Tew KD: The role of glutathione-S-transferase in anti-cancer drug resistance. Oncogene. 22:7369–7375. 2003. View Article : Google Scholar : PubMed/NCBI
9	Housman G, Byler S, Heerboth S, Lapinska K, Longacre M, Snyder N and Sarkar S: Drug resistance in cancer: An overview. Cancers (Basel). 6:1769–1792. 2014. View Article : Google Scholar : PubMed/NCBI
10	Searchfield L, Price SA, Betton G, Jasani B, Riccardi D and Griffiths DF: Glutathione S-transferases as molecular markers of tumour progression and prognosis in renal cell carcinoma. Histopathology. 58:180–190. 2011. View Article : Google Scholar : PubMed/NCBI
11	Zhuo R, Kosak KM, Sankar S, Wiles ET, Sun Y, Zhang J, Ayello J, Prestwich GD, Shami PJ, Cairo MS, et al: Targeting Glutathione S-transferase M4 in Ewing sarcoma. Front Pediatr. 2:832014. View Article : Google Scholar : PubMed/NCBI
12	Lu H, Chen I, Shimoda LA, Park Y, Zhang C, Tran L, Zhang H and Semenza GL: Chemotherapy-Induced Ca2+ release stimulates breast cancer stem cell enrichment. Cell Rep. 18:1946–1957. 2017. View Article : Google Scholar : PubMed/NCBI
13	Pan XD, Yang ZP, Tang QL, Peng T, Zhang ZB, Zhou SG, Wang GX, He B and Zang LQ: Expression and function of GSTA1 in lung cancer cells. Asian Pac J Cancer Prev. 15:8631–8635. 2014. View Article : Google Scholar : PubMed/NCBI
14	Cordoba EE, Abba MC, Lacunza E, Fernande E and Guerci AM: Polymorphic variants in oxidative stress genes and acute toxicity in breast cancer patients receiving radiotherapy. Cancer Res Treat. 48:948–954. 2016. View Article : Google Scholar : PubMed/NCBI
15	Eichholzer M, Rohrmann S, Barbir A, Hermann S, Teucher B, Kaaks R and Linseisen J: Polymorphisms in heterocyclic aromatic amines metabolism-related genes are associated with colorectal adenoma risk. Int J Mol Epidemiol Genet. 3:96–106. 2012.PubMed/NCBI
16	Nguyen TV, Janssen MJ, van Oijen MG, Bergevoet SM, te Morsche RH, van Asten H, Laheij RJ, Peters WH and Jansent JB: Genetic polymorphisms in GSTA1, GSTP1, GSTT1, and GSTM1 and gastric cancer risk in a Vietnamese population. Oncol Res. 18:349–355. 2010. View Article : Google Scholar : PubMed/NCBI
17	Deng Q, He B, Pan Y, Sun H, Liu X, Chen J, Ying H, Lin K, Peng H and Wang S: Polymorphisms of GSTA1 contribute to elevated cancer risk: Evidence from 15 studies. J BUON. 20:287–295. 2015.PubMed/NCBI
18	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
19	Adnan H, Quach H, MacIntosh K, Antenos M and Kirby GM: Low levels of GSTA1 expression are required for Caco-2 cell proliferation. PLoS One. 7:e517392012. View Article : Google Scholar : PubMed/NCBI
20	Liu K, Lin X, Zhou Q, Ma T, Han L, Mao G, Chen J, Yue X, Wang H, Zhang L, et al: The associations between two vital GSTs genetic polymorphisms and lung cancer risk in the Chinese population: Evidence from 71 studies. PLoS One. 9:e1023722014. View Article : Google Scholar : PubMed/NCBI
21	Ahn J, Gammon MD, Santella RM, Gaudet MM, Britton JA, Teitelbaum SL, Terry MB, Neugut AI, Eng SM, Zhang Y, et al: Effects of glutathione S-transferase A1 (GSTA1) genotype and potential modifiers on breast cancer risk. Carcinogenesis. 27:1876–1882. 2006. View Article : Google Scholar : PubMed/NCBI
22	Komiya Y, Tsukino H, Nakao H, Kuroda Y, Imai H and Katoh T: Human glutathione S-transferase A1, T1, M1, and P1 polymorphisms and susceptibility to prostate cancer in the Japanese population. J Cancer Res Clin Oncol. 131:238–242. 2005. View Article : Google Scholar : PubMed/NCBI
23	Martinez C, Martin F, Fernandez JM, García-Martín E, Sastre J, Díaz-Rubio M, Agúndez JA and Ladero JM: Glutathione S-transferases mu 1, theta 1, pi 1, alpha 1 and mu 3 genetic polymorphisms and the risk of colorectal and gastric cancers in humans. Pharmacogenomics. 7:711–718. 2006. View Article : Google Scholar : PubMed/NCBI
24	Matic M, Pekmezovic T, Djukic T, Mimic-Oka J, Dragicevic D, Krivic B, Suvakov S, Savic-Radojevic A, Pljesa-Ercegovac M, Tulic C, et al: GSTA1, GSTM1, GSTP1, and GSTT1 polymorphisms and susceptibility to smoking-related bladder cancer: A case-control study. Urol Oncol. 31:1184–1192. 2013. View Article : Google Scholar : PubMed/NCBI
25	Lo HW and Ali-Osman F: Genetic polymorphism and function of glutathione S-transferases in tumor drug resistance. Curr Opin Pharmacol. 7:367–374. 2007. View Article : Google Scholar : PubMed/NCBI
26	Dhanasekaran DN and Reddy EP: JNK signaling in apoptosis. Oncogene. 27:6245–6251. 2008. View Article : Google Scholar : PubMed/NCBI
27	Yang Y, Cheng JZ, Singhal SS, Saini M, Pandya U, Awasthi S and Awasthi YC: Role of glutathione S-transferases in protection against lipid peroxidation. Overexpression of hGSTA2-2 in K562 cells protects against hydrogen peroxide-induced apoptosis and inhibits JNK and caspase 3 activation. J Biol Chem. 276:19220–19230. 2001. View Article : Google Scholar : PubMed/NCBI
28	Romero L, Andrews K, Ng L, O'Rourke K, Maslen A and Kirby G: Human GSTA1-1 reduces c-Jun N-terminal kinase signalling and apoptosis in Caco-2 cells. Biochem J. 400:135–141. 2006. View Article : Google Scholar : PubMed/NCBI